200 related articles for article (PubMed ID: 19556961)
1. Tumor biomarkers in melanoma.
Ugurel S; Utikal J; Becker JC
Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
[TBL] [Abstract][Full Text] [Related]
3. Circulating biomarkers in malignant melanoma.
Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
[TBL] [Abstract][Full Text] [Related]
4. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
[TBL] [Abstract][Full Text] [Related]
5. Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.
Utikal J; Schadendorf D; Ugurel S
Arch Dermatol Res; 2007 Mar; 298(10):469-77. PubMed ID: 17221215
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma--markers for progression and prognosis in malignant melanoma.
Geilen CC; Georgieva J; Milling A; Farthmann B
Front Radiat Ther Oncol; 2006; 39():120-126. PubMed ID: 16394675
[No Abstract] [Full Text] [Related]
7. Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
Solassol J; Du-Thanh A; Maudelonde T; Guillot B
Int J Biol Markers; 2011; 26(2):82-7. PubMed ID: 21607923
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of melanoma-have we arrived?
Bordelon JR; Grichnik JM
Dermatol Ther; 2015; 28(6):405. PubMed ID: 26031627
[No Abstract] [Full Text] [Related]
9. Current staging and prognostic factors in melanoma.
Bartlett EK; Karakousis GC
Surg Oncol Clin N Am; 2015 Apr; 24(2):215-27. PubMed ID: 25769707
[TBL] [Abstract][Full Text] [Related]
10. [Molecular classification and markers of malignant melanoma].
Tímár J; Hársing J; Somlai B
Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
[TBL] [Abstract][Full Text] [Related]
11. The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma.
Bougnoux AC; Solassol J
Clin Biochem; 2013 Apr; 46(6):518-23. PubMed ID: 23262402
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
Van Laar R; Lincoln M; Van Laar B
Br J Cancer; 2018 Mar; 118(6):857-866. PubMed ID: 29360813
[TBL] [Abstract][Full Text] [Related]
14. New prognostic factors and developing therapy of cutaneous melanoma.
Vihinen PP; Pyrhönen SO; Kähäri VM
Ann Med; 2003; 35(2):66-78. PubMed ID: 12795336
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.
Tian R; Liu T; Qiao L; Gao M; Li J
Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.
Fischer GM; Carapeto FCL; Joon AY; Haydu LE; Chen H; Wang F; Van Arnam JS; McQuade JL; Wani K; Kirkwood JM; Thompson JF; Tetzlaff MT; Lazar AJ; Tawbi HA; Gershenwald JE; Scolyer RA; Long GV; Davies MA
Cancer Med; 2020 Nov; 9(22):8650-8661. PubMed ID: 33016647
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.
Hyams DM; Cook RW; Buzaid AC
J Surg Oncol; 2019 Jan; 119(2):175-186. PubMed ID: 30548543
[TBL] [Abstract][Full Text] [Related]
18. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C
Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176
[TBL] [Abstract][Full Text] [Related]
19. Melanoma with BRAF Mutation in Circulating Cell-free DNA despite no Mutation in the Primary Lesion: A Case Report.
Ashida A; Uhara H; Mikoshiba A; Sakaizawa K; Kumagai N; Koga H; Okuyama R
Acta Derm Venereol; 2016 Jan; 96(1):128-9. PubMed ID: 26123241
[No Abstract] [Full Text] [Related]
20. Gene expression profiling in melanoma: past results and future potential.
Knackstedt RW; Knackstedt T; Gastman B
Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
